---
layout: main
---

	<section id="one" class="wrapper alt style2">
		<section class="spotlight">
			<div class="image"><img src="images/pic01.jpg" alt="" /></div><div class="content">
				<h2>Development of Safer Gene Editing Technology Guided by Biophysical and Chemical Insights <br /> (CRISPR-Cas9, Cas12a, Cas1/Cas2)</h2>
				<p><strong>Research Questions: </strong> 
					<ol>
						<li>How does various mutations affect the confromational dynamics and catalysis of Cas9?</li>
						<li>What is the structural organization which allows for Cas12a to cleave two strands of DNA with a single active site?</li>
						<li>Can the DNA integration activity of Cas1 and Cas2 be modulated?</li>
					</ol> 
				</p>
			</div>
		</section>
		<section class="spotlight">
			<div class="image"><img src="images/pic02.jpg" alt="" /></div><div class="content">
				<h2>Targeting the acidic microenvironment of Pancreatic Cancer Cells with <br />pH Low Insertion Peptides (pHLIP)</h2>
				<p><strong>Research Question: </strong> 
					<ol>
						<li>What contribution does the solvent pH have to the stability of pHLIP inserted in cell membrane?</li>
						<li>How does the shift in pKa of titrable amino acid pKa assist in the binding and insertion processes?</li>
						<li>Can peptides be designed for optimal activity within a specific pH range?</li>
					</ol>
				</p>
			</div>
		</section>
		<section class="spotlight">
			<div class="image"><img src="images/pic03.jpg" alt="" /></div><div class="content">
				<h2>Structure-Based Drug Design for Biomedical Imaging of Neurological Diseases <br />(PET Tracers/<br />Bio-Chemiluminescent Probes)</h2>
				<p><strong>Research Question: </strong> 
					<ol>
						<li>How to identify neurological diseases in the early stages?</li>
					</ol>
				</p>
			</div>
		</section>
	</section>

	